Diagnostic dilemma of lobular carcinoma: a mini-review of imaging modalities and the role of artificial intelligence and radiomics [0.03%]
乳头状癌的诊断难题：影像模态的综述及人工智能和放射组学作用的研究进展-mini review
Sima Jabbari,Mariam Shadan,Yousef Eltayeb et al.
Sima Jabbari et al.
Lobular carcinoma (LC) presents unique diagnostic challenges due to its subtle imaging characteristics and asymptomatic presentation, often leading to delays in diagnosis and treatment. This mini-review critically examines both traditional ...
The relationship of depression and quality of life with mediating role of death anxiety, silver lining and religious coping among women cancer patients in Pakistan [0.03%]
巴基斯坦女性癌症患者抑郁症和生活质量与死亡焦虑、银线和宗教应对的介导作用关系研究
Wizra Saeed
Wizra Saeed
Objective: Pakistani women are among those most likely to be diagnosed with cancer. Cancer patients experience significant changes that impact their mental and physical health, primarily due to the increased burden of the...
Boundary aware microscopic hyperspectral pathology image segmentation network guided by information entropy weight [0.03%]
基于信息熵权的边界感知微观高光谱病理图像分割网络
Xueying Cao,Hongmin Gao,Ting Qin et al.
Xueying Cao et al.
Introduction: Accurate segmentation of lesion tissues in medical microscopic hyperspectral pathological images is crucial for enhancing early tumor diagnosis and improving patient prognosis. However, the complex structure...
Corrigendum: Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study [0.03%]
correction: 晚期非鳞状非小细胞肺癌患者的靶向治疗及生存率—一项全国性队列研究
Johanne Elise Nyen,Anja Ødegård Booth,Øyvind Husby et al.
Johanne Elise Nyen et al.
[This corrects the article DOI: 10.3389/fonc.2025.1506041.]. Keywords: ALK; EGFR; ROS; lung cancer; real wor...
Published Erratum
Frontiers in oncology. 2025 Mar 26:15:1595028. DOI:10.3389/fonc.2025.1595028 2025
Potent estrogen receptor β agonists with inhibitory activity in vitro, fail to suppress xenografts of endocrine-resistant cyclin-dependent kinase 4/6 inhibitor-resistant breast cancer cells [0.03%]
高效雌激素受体β激动剂的体内抑制活性缺失：在内分泌耐药和CDK4/6抑制剂耐药乳腺癌异种移植模型中的失败
Lynn M Marcho,Christopher C Coss,Menglin Xu et al.
Lynn M Marcho et al.
Objective: Seventy percent of newly diagnosed breast cancers are estrogen receptor-α positive and HER2/neu negative. First-line treatments incorporate endocrine therapy and cyclin-dependent kinase 4/6 inhibitors. However...
Mingshan Wang,Yong Fu,Xiaowen Liu et al.
Mingshan Wang et al.
Background: Liposarcoma of the spermatic cord is an extremely rare urological malignancy, with fewer than 300 cases reported in the literature worldwide, and it is often difficult to distinguish from inguinal hernias and ...
Case Report: Atypical prostate cancer presentation: rectal bleeding, pain, and psoriasiform dermatitis [0.03%]
病例报告：前列腺癌的非典型表现：便血、疼痛和银屑病型皮炎
Frank Obeng,Aishah Fadila Adamu,Samuel Edudzi Gavor et al.
Frank Obeng et al.
Prostate cancer is typically asymptomatic and usually diagnosed through concerted screening programs. However, in settings where there are no existing national prostate cancer screening programs, it may be picked up at the clinics in patien...
A feasibility study of deep learning prediction model for VMAT patient-specific QA [0.03%]
VMAT患者特定质控的深度学习预测模型的可行性研究
Junjie Miao,Yuan Xu,Kuo Men et al.
Junjie Miao et al.
Purpose: This study introduces a deep learning (DL) model that leverages doses calculated from both a treatment planning system (TPS) and independent dose verification software using Monte Carlo (MC) simulations, aiming t...
Efficacy of repeat hepatectomy versus radiofrequency ablation for recurrent hepatocellular carcinoma: a Systematic Review and meta-analysis [0.03%]
重复肝切除术与射频消融治疗复发性肝细胞癌疗效的系统评价和meta分析
Qingchen Meng,Xiaohang Li,Hongxin Lang
Qingchen Meng
Background: This article compared the efficacy and safety of repeat hepatectomy (RH) and radiofrequency ablation (RFA) for the treatment of recurrent hepatocellular carcinoma (RHCC) from multiple perspectives. ...
Advances in bevacizumab in colorectal cancer: a bibliometric analysis from 2004 to 2023 [0.03%]
2004至2023年贝伐珠单抗在结直肠癌领域的发展趋势：基于文献计量分析的研究进展综述
Hao Chen,Yeqing Lei,Junjie Zhou et al.
Hao Chen et al.
Background: Bevacizumab is a primary focus in the clinical application and research of metastatic colorectal cancer (mCRC) patients. This study aims to analyze publications on bevacizumab and CRC to explore and identify t...